Skip to main content

 Related scientific articles (all)

Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911).

Authors : Bolla M, Van Poppel H, Tombal B, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, Van Velthoven R, Colombel M, van de Beek C, Verhagen P, Van den Bergh A, Sternberg C, Gasser T, Van Tienhoven G, Scalliet P, Haustermans K, Collette L
Year : 2012
Journal : Lancet
Volume : 380(9858)
Pages : 2018-27

Esophageal self-expanding metallic stent (SEMS) migration: it's a topsy-turvy world.

Authors : Toussaint E, Zalcman M, Devière J, Le Moine O, Arvanitakis M
Year : 2012
Journal : Endoscopy
Volume : 44 Suppl 2
Pages : E352-3

Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets.

Authors : Salaun B, Yamamoto T, Badran B, Tsunetsugu-Yokota Y, Roux A, Baitsch L, Rouas R, Fayyad-Kazan H, Baumgaertner P, Devevre E, Ramesh A, Braun M, Speiser D, Autran B, Martiat P, Appay V, Romero P
Year : 2011
Journal : J Transl Med
Volume : 9(null)
Pages : 44

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death : meta-analysis of individual patient data for 10,801 women in 17 randomised trials.(Early Breast Cancer Trialists’ Collaborative Group (Ebct

Authors : Darby S, Mcgale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, Gray R, Pierce L, Whelan T, Wang Y, Peto R
Year : 2011
Journal : Lancet
Volume : 378 (9804)
Pages : 1707-16

Postoperative radiotherapy in non-small cell lung cancer.

Authors : Roelandts M, Moretti L, Van Houtte P
Year : 2011
Journal : Cancer Radiother
Volume : 15(6-7)
Pages : 514-7

MLN8054, a small molecule inhibitor of aurora kinase a, sensitizes androgen-resistant prostate cancer to radiation.

Authors : Moretti L, Niermann K, Schleicher S, Giacalone NJ, Varki V, Kim KW, Kopsombut P, Jung DK, Lu B
Year : 2011
Journal : Int J Radiat Oncol Biol Phys
Volume : 80(4)
Pages : 1189-97

Long-term toxic effects of adjuvant chemotherapy in breast cancer.

Authors : Azim HA, de Azambuja E, Colozza M, Bines J, Piccart-Gebhart M
Year : 2011
Journal : Ann Oncol
Volume : 22(9)
Pages : 1939-47

Radiotherapy of lung cancer: Any room left for elective mediastinal irradiation in 2011?

Authors : Van Houtte P, Roelandts M, Mornex F
Year : 2011
Journal : Cancer Radiother
Volume : 15(6-7)
Pages : 509-13

Breast cancer: towards an evolution of minimalist locoregional therapy.

Authors : Nogaret JM
Year : 2011
Journal : Bull. Mem. Acad. R. Med. Belg.
Volume : 166(5-6)
Pages : 229-32; discussion 233-4

An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole.

Authors : Jacobs F, Selleslag D, Aoun M, Sonet A, Gadisseur A
Year : 2011
Journal : Eur J Clin Microbiol Infect Dis
Volume : 31(6)
Pages : 1173-9

Practical use of GenoType HelicoDR, a molecular test for Helicobacter pylori detection and susceptibility testing

Authors : Miendje Deyi VY, Burette A, Bentatou Z, Maaroufi Y, Bontems P, Lepage P, Reynders M
Year : 2011
Journal : Diagn Microbiol Infect Dis
Volume : 70(4)
Pages : 557-60

Beyond trastuzumab: new treatment options for HER2-positive breast cancer.

Authors : Saini KS, Azim HA, Metzger-Filho O, Loi S, Sotiriou C, de Azambuja E, Piccart-Gebhart M
Year : 2011
Journal : Breast
Volume : 20 Suppl 3
Pages : S20-7

Therapeutic advances in non-small cell lung cancer.

Authors : Vallières E, Peters S, Van Houtte P, Dalal P, Lim E
Year : 2011
Journal : Thorax
Volume : 67
Pages : 1097-101

Peptides targeting estrogen receptor alpha-potential applications for breast cancer treatment.

Authors : Leclercq G, Gallo D, Cossy J, Laïos I, Larsimont D, Laurent G, Jacquot Y
Year : 2011
Journal : Curr. Pharm. Des.
Volume : 17(25)
Pages : 2632-53

Parathyroid carcinoma: a review with three illustrative cases.

Authors : Digonnet A, Carlier A, Willemse E, Quiriny M, Dekeyser C, de Saint-Aubain de Somerhausen N, Lemort M, Andry G
Year : 2011
Journal : J Cancer
Volume : 2(null)
Pages : 532-7

Leukemia-free survival as a surrogate end point for overall survival in the evaluation of maintenance therapy for patients with acute myeloid leukemia in complete remission.

Authors : Buyse M, Michiels S, Squifflet P, Lucchesi KJ, Hellstrand K, Brune ML, Castaigne S, Rowe JM
Year : 2011
Journal : Haematologica
Volume : 96(8)
Pages : 1106-12

HER2-overexpressing breast cancer: time for the cure with less chemotherapy?

Authors : Loi S, de Azambuja E, Pugliano L, Sotiriou C, Piccart-Gebhart M
Year : 2011
Journal : Curr Opin Oncol
Volume : 23(6)
Pages : 547-58

New Imaging Techniques for 90Y Microsphere Radioembolization.

Authors : Vouche M, Vanderlinden B, Delatte P, Lemort M, Hendlisz A, Deleporte A, Garcia C, Flamen P
Year : 2011
Journal : J Nucl Med Radiat Ther
Volume : 2
Pages : 113

Proteomic changes associated with breast cancer progression in the MCF10AT model.

Authors : Fumagalli D, Michiels S, Sotiriou C
Year : 2011
Journal : Pharmacogenomics
Volume : 12(1)
Pages : 9-10

Tyrosinase related protein 1 (TYRP1 / gp75) in human cutaneous melanoma.

Authors : Ghanem G, Journe F
Year : 2011
Journal : Mol oncol
Volume : 5(2)
Pages : 150-155